Narcan is the best-known brand name for naloxone hydrochloride, an opioid antagonist that rapidly reverses an opioid overdose by blocking opioid receptors in the brain. Emergent BioSolutions manufactures the branded 4 mg nasal spray. The FDA approved Narcan for over-the-counter sale in March 2023, the first naloxone product available without a prescription. Kloxxado is a higher-dose 8 mg prescription nasal spray from Hikma, and Zimhi and RiVive are additional naloxone formulations, including a lower-cost generic nasal spray line that competes directly with Narcan at the pharmacy counter.
Padagis received FDA approval for the first generic over-the-counter naloxone nasal spray in July 2023, and it launched later that year priced roughly $10 to $15 below brand Narcan. Amneal followed with a second generic OTC naloxone spray in 2024. By 2026, most major pharmacy chains stock both the brand and at least one generic naloxone nasal spray side by side on the shelf, no pharmacist consultation or prescription required in any state. This guide breaks down the real 2026 cash price, what Medicaid and Medicare Part D actually pay for, and where to get naloxone completely free.
Naloxone was not selected in either round of Medicare drug price negotiation under the Inflation Reduction Act of 2022, so there is no negotiated Maximum Fair Price for Narcan or its generics. The bigger 2026 policy story is coverage continuity: the over-the-counter switch technically removed naloxone from the category Medicare Part D is required to cover, since Part D by law covers only prescription drugs. States and health plans have responded with pharmacist standing orders that let Medicaid and many commercial plans keep paying for naloxone without an individual doctor's prescription.
What Narcan Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same narcan can cost many times more at a hospital than at your local pharmacy:
2026 Narcan Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter, brand Narcan (OTC, cash) | $45 - $50 per 2-dose box | No prescription needed in any state as of 2026 |
| Pharmacy counter, generic naloxone (OTC, cash) | $25 - $40 per 2-dose box | Padagis and Amneal generics; same active ingredient and dose as Narcan |
| Medicaid (2026) | $0 - $4 copay, or $0 under state naloxone-specific waivers | Requires a standing-order prescription in your state; every state Medicaid program covers naloxone |
| Medicare Part D / Part B (2026) | $0 - $10 copay only with a written prescription; $0 if administered in a covered clinical setting under Part B | A straight OTC cash purchase generally is not reimbursed by Part D because Part D covers prescription drugs only |
| Free public health distribution | $0, no insurance or income proof required | State health departments, NEXT Distro mail program, and SAMHSA-funded harm reduction organizations |
Retail prices reflect 2026 GoodRx, SingleCare, and chain-pharmacy shelf pricing. Free-program availability varies by state and by supply on hand.
Source: FDA OTC naloxone approvals, GoodRx, SingleCare, SAMHSA Opioid Overdose Reversal Medications program, state Medicaid agencies
Why Hospitals Charge So Much
Ambulance crews and emergency rooms bill naloxone as part of a resuscitation encounter rather than a standalone retail purchase, and that changes the price dramatically. Industry billing data shows a single administered Narcan dose can run $65 or more once EMS medication, administration, and mileage charges are combined, and some regional ambulance services have billed a single naloxone bottle at $98 in addition to the base transport fee. A drug that costs $25 to $50 for a full 2-dose box at the pharmacy can appear on an ambulance or ER bill as a $150 to $800 line item once facility, supply, and administration fees are layered on top.
Ground ambulance transport is not covered by the federal No Surprises Act, so a naloxone-related ambulance bill can still surprise a patient even after 2022 balance-billing reforms took effect for hospitals and air ambulances. Emergency departments separately bill naloxone under HCPCS code J2312 (injection, naloxone hydrochloride, not otherwise specified, 0.01 mg), and because that code is denominated in tiny 0.01 mg units, a typical 2 mg to 4 mg emergency dose shows up as 200 to 400 billing units on an itemized statement. That large unit count is mathematically correct, not fraudulent, but it is worth confirming against the actual dose given.
HCPCS J-Codes: What Appears on Your Bill
HCPCS code J2312 replaced the older J2310 code for injectable naloxone hydrochloride, effective mid-2025, and remains the active Part B billing code for naloxone administered in a clinical or ambulance setting in 2026.
HCPCS J-codes for Narcan| Code | Description | What to look for |
|---|
| J2312 | Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg | Confirm the billed unit count matches the actual milligrams given (multiply mg by 100 to get units). Watch for a separate ambulance mileage or administration fee stacked on top of the drug charge. |
This code applies to naloxone administered by EMS or hospital staff and billed under Medicare Part B or commercial medical benefits, not to an OTC pharmacy purchase.
Source: CMS HCPCS Level II code set, 2025-2026 update cycle
Patient Assistance Programs
Narcan does not have a traditional income-gated manufacturer patient assistance program the way many chronic-disease drugs do, because the drug's 2026 cash price is already low and public health agencies distribute it free at scale. Free naloxone access does not require proof of income the way a 400 percent federal poverty level manufacturer coupon might for a brand-name specialty drug.
Patient assistance programs for Narcan| Manufacturer program | Cost / Benefit | How to apply |
|---|
| NEXT Distro Free Naloxone Mail Program | Free naloxone kit mailed to your home in most states, no income requirement | nextdistro.org |
| State Health Department Naloxone Distribution | Free or low-cost naloxone through state opioid response and syringe services programs | your state health department website |
| SAMHSA Opioid Overdose Reversal Medications initiative | Federal grant funding for free naloxone kits and training distributed through community and harm-reduction organizations | samhsa.gov |
| NeedyMeds Naloxone Locator and Drug Discount Card | Free directory of local no-cost naloxone sites plus a discount card usable at most US pharmacies | needymeds.org |
| GoodRx / SingleCare pharmacy discount coupon | As low as $26 to $43 for a 2-dose box at CVS, Walmart, Kroger, or Walgreens with a free coupon | goodrx.com/narcan |
Narcan currently has no manufacturer commercial copay card, so the usual federal anti-kickback statute (42 U.S.C. section 1320a-7b) restriction on Medicare and Medicaid beneficiaries using manufacturer coupons does not create the same barrier it does for chronic specialty drugs. Pharmacy discount cards like GoodRx are not manufacturer copay assistance, so Medicare and Medicaid beneficiaries can generally use them, but only if they pay cash with the discount card price instead of also running the purchase through their Medicare Part D or Medicaid claim on the same transaction.
Source: NEXT Distro, SAMHSA Opioid Overdose Reversal Medications program, NeedyMeds, GoodRx
Medicare Part D
Medicare Part D by statute covers only prescription drugs, and Narcan's March 2023 switch to over-the-counter status removed most retail purchases from that category. A record 600,000-plus Medicare beneficiaries used Part D to get naloxone in 2022, the year before the OTC switch, so this is a real coverage gap for some Medicare enrollees who relied on their Part D plan and a doctor's prescription. In 2026, a Medicare beneficiary who gets a written prescription for naloxone from a doctor can sometimes still have it processed through Part D depending on the plan's formulary tier and whether the plan chooses to cover the OTC product as a supplemental benefit.
Medicare Part B separately covers naloxone and nalmefene (a similar opioid overdose reversal drug) when administered to rapidly reverse an overdose, typically in a clinical or emergency setting, billed under HCPCS J2312. That Part B coverage is unrelated to buying a box off the pharmacy shelf. Medicare Advantage plans increasingly include naloxone in their over-the-counter benefit allowance, a separate quarterly OTC spending card some MA plans offer, which can cover the cash price of a Narcan or generic naloxone box even without a prescription.
Naloxone was not included in either round of Inflation Reduction Act Medicare drug price negotiation, so it falls outside the negotiated Maximum Fair Price program and outside the drug-specific $35 monthly cap that applies only to insulin. Instead, a Medicare beneficiary who does get naloxone through a Part D prescription has that cost count toward the general 2026 Part D annual out-of-pocket cap of $2,100 along with all other covered drugs.
Common Narcan Billing Errors
If you were charged more than $50 for a 2-dose box of naloxone at the pharmacy, or you got a surprise ambulance or ER bill for a Narcan dose, check for these issues before paying:
- Being told you need a prescription at all. Every state allows OTC purchase of naloxone without one as of 2026; a pharmacy that insists otherwise is misinformed.
- Paying full brand price without being offered the generic naloxone nasal spray, which is chemically identical and typically $10 to $20 cheaper.
- A Medicaid claim rejected for lack of a prescription when your state has a naloxone standing order in place; the pharmacist can bill under the standing order instead of an individual prescription.
- An ambulance bill listing naloxone as a large number of billing units (200 to 400) under HCPCS J2312 without confirming that matches the actual milligrams administered.
- Trying to use a pharmacy discount coupon at the same time as a Medicare Part D or Medicaid claim on one transaction; you must choose the cash discount price or the insurance claim, not both.
Frequently Asked Questions
Is there a generic version of Narcan?
Yes. Padagis launched the first generic over-the-counter naloxone nasal spray in 2023 after FDA approval in July 2023, and Amneal launched a second generic in 2024. Generic naloxone nasal spray is chemically identical to brand Narcan and typically costs $10 to $20 less per 2-dose box in 2026. Because naloxone is a small-molecule drug rather than a biologic, there is no biosimilar involved, only standard generic competition.
How do I get free naloxone if I cannot afford it?
Visit nextdistro.org, a national harm-reduction nonprofit that mails free naloxone to most states with no income requirement. You can also contact your state health department's opioid response program, search the NeedyMeds naloxone locator, or ask a local SAMHSA-funded harm reduction organization. None of these public health programs require proof of income, insurance status, or a formal patient assistance program application the way many chronic-disease drug manufacturer programs do.
Can I use a Narcan discount coupon with Medicare or Medicaid?
Narcan does not currently have a manufacturer commercial copay card, so the usual anti-kickback statute restriction that blocks Medicare and Medicaid beneficiaries from combining a manufacturer coupon with a federal insurance claim mostly does not apply here. Pharmacy discount cards like GoodRx or SingleCare are different: Medicare and Medicaid beneficiaries can generally use them, but only by paying the cash discount price outright rather than also billing the same purchase to Medicare Part D or Medicaid.
What happens if my insurance denies coverage for naloxone?
Request the written denial and appeal within your plan's deadline, typically 60 days for Medicare Part D. Ask your prescriber to cite your state's naloxone standing order if the denial was based on lacking an individual prescription, since nearly every state allows pharmacists to dispense under a generalized standing order. If the appeal fails or you need naloxone immediately, buy it over the counter for $25 to $50 without insurance, or get it free through NEXT Distro or your state health department.
Does the Inflation Reduction Act's Maximum Fair Price apply to Narcan?
No. Naloxone was not selected in either round of Medicare drug price negotiation under the Inflation Reduction Act of 2022, so there is no negotiated Maximum Fair Price for Narcan or its generics. If you do get naloxone through a Medicare Part D prescription, its cost counts toward the standard 2026 Part D annual out-of-pocket cap of $2,100, the same cap that applies to every other covered Part D drug.
What does Narcan cost without insurance at the pharmacy counter in 2026?
Brand-name Narcan costs $45 to $50 for a 2-dose nasal spray box without insurance in 2026 at chains like CVS and Walgreens. Generic naloxone nasal spray costs $25 to $40 for the same 2-dose box at Walmart, Costco, Kroger, and most other pharmacies. A free GoodRx or SingleCare coupon can bring either product down to as low as $26 at participating pharmacies, and no prescription is required to buy it.
Does Medicaid cover naloxone?
Yes, every state Medicaid program covers naloxone, typically with a $0 to $4 copay, though several states have eliminated the copay entirely for naloxone specifically as part of opioid response policy. Because naloxone is now over-the-counter, Medicaid coverage generally requires your pharmacist to dispense it under your state's naloxone standing order rather than an individual doctor's prescription.
What is the difference between Narcan and Kloxxado?
Narcan delivers a 4 mg dose of naloxone per spray and is available over the counter without a prescription in 2026. Kloxxado delivers a higher 8 mg dose per spray, made by Hikma, and remains available by prescription for people at higher risk of exposure to potent synthetic opioids like fentanyl. Kloxxado typically costs significantly more, around $130 to $200 for a 2-dose box without insurance, and may require prior authorization or a step-therapy override from some insurance plans before it is covered over the standard 4 mg dose.
